Drug name - Qinlock

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8188113 DECIPHERA PHARMS Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
Jul, 2030

(7 years from now)

US8461179 DECIPHERA PHARMS Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
Jun, 2032

(9 years from now)

CN101516379A DECIPHERA PHARMS Kinase Inhibitors For The Treatment Of Proliferative Diseases
Jan, 2013

(9 years ago)

CN101553232A DECIPHERA PHARMS Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases
Nov, 2013

(8 years ago)

IN253776B DECIPHERA PHARMS Kinase Inhibitors Useful For The Treatment Of Proliferative Diseases
Sep, 2027

(4 years from now)

IN200900461P3 DECIPHERA PHARMS Kinase Inhibitirs Useful For The Treatment Of Proliferative Diseases
Sep, 2027

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
USRE48731 DECIPHERA PHARMS Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases Jun, 2032

(9 years from now)

US10966966 DECIPHERA PHARMS Methods of treating gastrointestinal stromal tumors Aug, 2040

(17 years from now)

US11185535 DECIPHERA PHARMS Amorphous kinase inhibitor formulations and methods of use thereof Dec, 2040

(18 years from now)

Drugs and Companies using RIPRETINIB ingredient

Treatment: Treatment of gastrointestinal stromal tumor; Treatment of advanced gastrointestinal stromal tumor in patients having progressed from a first line administration of imatinib, a second line administration of sunitinib, and a third line administration of regorafenib

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
50MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.